Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Locally advanced and metastatic basal cell carcinoma, drawn from the whole corpus: 9 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Hedgehog inhibitor side effects lead many patients to stop before the tumour is controlled.
Nothing recorded yet.
Also on OnCo: Side effects by symptom · Immune-related side effects · Toxicity compare · Survivorship planner.
Only about a third of patients respond to cemiplimab after hedgehog inhibitor failure and there is no third line.
Advanced disease is largely a failure of access and neglect, since almost every tumour is curable when small.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Atlas of advanced disease · How cancer spreads: the metastasis stages.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 12 changes by month →When this page itself was last checked or edited.
Advanced basal cell carcinoma after hedgehog inhibitor
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
Locally advanced BCC recurrent after surgery or radiation, or not candidates
Objective response at 200 mg: 43% in locally advanced and 15% in metastatic basal cell carcinoma (central review).